Market Overview

UPDATE: Bank of America Downgrades Humana to Neutral on Reimbursement Headwinds

Share:
Related HUM
Jim Cramer Shares His Thoughts On Humana And Starbucks
Response To GOP Healthcare Bill Ranges From Tepid Support To Outright Opposition
House Speaker Ryan postpones news conference on AHCA vote on apparent last-minute push for votes; hospital shares rally (Seeking Alpha)

Bank of America lowered its rating on Humana (NYSE: HUM) from Buy to Neutral and reduced its price objective from $89 to $83.

Bank of America noted, "The operating environment will be more difficult for MA plans under HC Reform and the reimbursement outlook in 2014 and 2015 create significant headwinds during a time period where cost trend is not likely to be as modest as it has been over the past few years, reducing the company's margin for error. However, we expect 2013 guidance has reset the bar low and given HUM's scale and track record, we believe that they will weather this storm better than most."

Humana closed at $76.16 on Tuesday.

Latest Ratings for HUM

DateFirmActionFromTo
Jan 2017Bank of AmericaReinstatesBuy
Jan 2017Stifel NicolausDowngradesBuyHold
Jan 2017PiperJaffrayInitiates Coverage OnOverweight

View More Analyst Ratings for HUM
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (HUM)

View Comments and Join the Discussion!